InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Quirk Michael C.. Director active across 1 company, notably Sage Therapeutics, Inc.. Cumulatively, 4 reports have been published. Activity tracked since 1 April 2025. The latest transaction was filed on 24 June 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Quirk Michael C. is a declarant linked to Sage Therapeutics, Inc. on XNAS, with a role listed as See Remarks. The record shows 4 filings in total, and the sampled recent filings run from 2025-04-02 to 2025-07-31, with the dominant transaction nature listed as Attribution.